CD8 (TIL) MicroBeads, mouse

CD8 (TIL) MicroBeads, mouse have been optimized for the isolation of CD8
+
tumor-infiltrating lymphocytes from mouse tumors.

Data and images for CD8 (TIL) MicroBeads, mouse

Figures

Figure 1

A tumor induced by the B16-OVA cell line was dissociated using the gentleMACS™ Octo Dissociator with Heaters in combination with the Tumor Dissociation Kit, mouse. CD8
+
TILs were isolated from the single-cell suspension using CD8 (TIL) MicroBeads, two MS Columns, and a MiniMACS™ Separator. Cells were fluorescently stained with CD8b-VioBlue
®
and CD4-PE-Vio
®
615 and analyzed by flow cytometry using the MACSQuant
®
Analyzer. Cell debris and dead cells were excluded from the analysis based on scatter signals and Viobility™ 405/520 Fixable Dye fluorescence.
Before separation
CD8
+
cells
View details

Figure 1

A tumor induced by the B16-OVA cell line was dissociated using the gentleMACS™ Octo Dissociator with Heaters in combination with the Tumor Dissociation Kit, mouse. CD8
+
TILs were isolated from the single-cell suspension using CD8 (TIL) MicroBeads, two MS Columns, and a MiniMACS™ Separator. Cells were fluorescently stained with CD8b-VioBlue
®
and CD4-PE-Vio
®
615 and analyzed by flow cytometry using the MACSQuant
®
Analyzer. Cell debris and dead cells were excluded from the analysis based on scatter signals and Viobility™ 405/520 Fixable Dye fluorescence.
View details

Figure 1

A tumor induced by the B16-OVA cell line was dissociated using the gentleMACS™ Octo Dissociator with Heaters in combination with the Tumor Dissociation Kit, mouse. CD8
+
TILs were isolated from the single-cell suspension using CD8 (TIL) MicroBeads, two MS Columns, and a MiniMACS™ Separator. Cells were fluorescently stained with CD8b-VioBlue
®
and CD4-PE-Vio
®
615 and analyzed by flow cytometry using the MACSQuant
®
Analyzer. Cell debris and dead cells were excluded from the analysis based on scatter signals and Viobility™ 405/520 Fixable Dye fluorescence.

Specifications for CD8 (TIL) MicroBeads, mouse

Overview

CD8 (TIL) MicroBeads, mouse have been optimized for the isolation of CD8
+
tumor-infiltrating lymphocytes from mouse tumors.

Detailed product information

Background information

CD8 (TIL) MicroBeads, mouse enable a positive selection of CD8
+
lymphocytes from solid mouse tumors, e.g., CT26.WT, 4T1, and B16F10 and have specifically been developed for an optimal isolation of tumor-infiltrating lymphocytes (TILs) from mouse tumors. The CD8 antigen is expressed on cytotoxic T cells.

Columns

MS, LS, autoMACS
®
Columns, or Multi-24 Column Blocks

Resources for CD8 (TIL) MicroBeads, mouse

Documents and Protocols

Brochures/posters

Tumor-infiltrating leukocytes - Optimized solutions for TIL research

Scientific posters

Optimized workflow improves the characterization of tumor-infiltrating T cells

Related products for
CD8 (TIL) MicroBeads, mouse

7 products available | view all
 

CD4 (TIL) MicroBeads, mouse

CD4 (TIL) MicroBeads, mouse have been optimized for the isolation of CD4+ tumor-infiltrating ...

 

CD4/CD8 (TIL) MicroBeads, mouse

CD4/CD8 (TIL) MicroBeads, mouse have been optimized for the isolation of CD4+ and CD8+ ...

 

CD45 (TIL) MicroBeads, mouse

CD45 (TIL) MicroBeads, mouse have been optimized for the isolation of tumor-infiltrating leukocytes ...

130-096-427

gentleMACS™ Octo Dissociator with Heaters

The gentleMACS™ Octo Dissociator with Heaters is a benchtop instrument for the fully automated and ...

130-096-730

Tumor Dissociation Kit, mouse

The Tumor Dissociation Kit, mouse has been developed for the gentle and rapid generation of ...

130-045-201

CD8 MicroBeads, human

CD8 MicroBeads were developed for the positive selection or depletion of human cytotoxic CD8+ T ...

130-111-716

CD8b Antibody, anti-mouse, VioBlue
®
, REAfinity™

Clone REA793 recognizes both alloantigeneic forms of the mouse CD8b antigen, a single-pass type I ...

Seems like you are coming from USA!
Do you want to visit our website in your country?

Copyright © 2022 Miltenyi Biotec and/or its affiliates. All rights reserved.